These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 24282168)

  • 1. Stimulant medication for ADHD not associated with subsequent substance use disorders.
    Riggs PD
    Evid Based Med; 2014 Apr; 19(2):78. PubMed ID: 24282168
    [No Abstract]   [Full Text] [Related]  

  • 2. Review: no evidence that stimulant medication for ADHD influences lifetime risk of substance use or dependence.
    Poulton A
    Evid Based Ment Health; 2014 Feb; 17(1):16. PubMed ID: 24104557
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of stimulant medications for attention-deficit/hyperactivity disorder on later substance use and the potential for stimulant misuse, abuse, and diversion.
    Faraone SV; Wilens TE
    J Clin Psychiatry; 2007; 68 Suppl 11():15-22. PubMed ID: 18307377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does stimulant treatment lead to substance use disorders?
    Faraone SV; Wilens T
    J Clin Psychiatry; 2003; 64 Suppl 11():9-13. PubMed ID: 14529324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
    Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulant treatment for ADHD may not increase risk of substance abuse.
    Harv Ment Health Lett; 2008 Jun; 24(12):7. PubMed ID: 18946888
    [No Abstract]   [Full Text] [Related]  

  • 7. Do conduct problems and sensation seeking moderate the association between ADHD and three types of stimulant use in a college population?
    Van Eck K; Markle RS; Flory K
    Psychol Addict Behav; 2012 Dec; 26(4):939-47. PubMed ID: 22428861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
    McCabe SE; Dickinson K; West BT; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attention-deficit/hyperactivity disorder and substance abuse.
    Harstad E; Levy S;
    Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.
    Schubiner H
    CNS Drugs; 2005; 19(8):643-55. PubMed ID: 16097847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulant therapy and risk for subsequent substance use disorders in male adults with ADHD: a naturalistic controlled 10-year follow-up study.
    Biederman J; Monuteaux MC; Spencer T; Wilens TE; Macpherson HA; Faraone SV
    Am J Psychiatry; 2008 May; 165(5):597-603. PubMed ID: 18316421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulant medication for ADHD in opioid maintenance treatment.
    Abel KF; Bramness JG; Martinsen EW
    J Dual Diagn; 2014; 10(1):32-8. PubMed ID: 25392060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder.
    Groenman AP; Oosterlaan J; Rommelse NN; Franke B; Greven CU; Hoekstra PJ; Hartman CA; Luman M; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
    Br J Psychiatry; 2013 Aug; 203(2):112-9. PubMed ID: 23846996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulant treatment of ADHD and risk of sudden death in children.
    Vitiello B; Towbin K
    Am J Psychiatry; 2009 Sep; 166(9):955-7. PubMed ID: 19528196
    [No Abstract]   [Full Text] [Related]  

  • 15. Respiratory toxicities from stimulant use.
    Albertson TE; Walby WF
    Clin Rev Allergy Immunol; 1997; 15(3):221-41. PubMed ID: 9358986
    [No Abstract]   [Full Text] [Related]  

  • 16. Stimulant Use Disorders.
    Park TM; Haning WF
    Child Adolesc Psychiatr Clin N Am; 2016 Jul; 25(3):461-71. PubMed ID: 27338967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J
    J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.
    Faraone SV; Biederman J; Wilens TE; Adamson J
    Psychol Med; 2007 Dec; 37(12):1743-52. PubMed ID: 17349106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential for misuse and abuse of medications in ADHD: a review.
    Clemow DB; Walker DJ
    Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulant treatment for ADHD.
    Verma R; Apala ; Kumari S; Dhiman V
    Br J Psychiatry; 2014 Jun; 204(6):490. PubMed ID: 25029692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.